Videos

Glenn Tillotson, PhD, FIDSA, discusses the costs of drug development.

Edmond Hooker, MD, DrPH, discusses how contaminated hospital mattresses act as a vector for spreading drug-resistant infections.

Dr. Richard Vickers, discusses how ridinilazole showed superior efficacy for the treatment of C. diff when compared with vancomycin in a phase 2 study.

Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.

Robert Bransfield, MD, DLFAPA, explains how open minds are needed to understand how infections can impact cognitive function and conduct.

Marin H. Kollef, MD, discusses the mortality and health care costs associated with Pseudomonas infections.

Barley Chironda, RPN, CIC, discusses current guidance for disinfection practices against C. diff.

Leonard Sigal, MD, explains the term “Lyme anxiety” and its association with a chronic Lyme disease diagnosis.

Edmond Hooker, MD, DrPH, discusses the cost benefit of investing in launderable hospital mattress covers to prevent CDIs.

Dr. Richard Vickers, explains how ridinilazole is unique in its spectrum of activity compared with other antibiotics that target C. diff and have been approved or are in development.

Richard Haupt, MD, MPH, discusses what would be required to adequately implement the delivery of a future C. diff vaccine.

Robert Bransfield, MD, DLFAPA, discusses research that explores how some infectious diseases can make individuals homicidal.

Barley Chironda, RPN, CIC, explains what the “chain of infection” is and what is needed to break it.

Leonard Sigal, MD, explains the potential adverse consequences of long-term antibiotic therapy.

Dr. Richard Vickers, explains how antibiotics used to treat C. diff also damage the microbiome.

William Schaffner, MD explains why pregnant women should get vaccinated against flu.

Robert Bransfield, MD, DLFAPA, discusses how to bridge the gap between psychiatrists and infectious disease physicians.

Edmond Hooker, MD, DrPH, discusses the use of a launderable mattress cover to reduce C. diff rates in hospitals.

William Schaffner, MD, explains why dogs cannot catch flu from humans.

Richard Haupt, MD, MPH, sheds light on the Clostridium difficile Vaccine Efficacy Trial (CLOVER).

Daniel Diekema, MD, explains how clinicians can actively work to prevent pathogen spread in their health care facilities.

Pedro Cahn, MD, describes the risk associated with raltegravir HD.

Leonard Sigal, MD, explains why Lyme disease is sometimes overdiagnosed or overtreated.

William Schaffner, MD, discusses efforts to develop a universal flu vaccine.

Dr. Richard Vickers, explains what makes ridinilazole unique.

Michael Edmond, MD, MPH, MPA, stresses that a collaborative effort is needed to control C. difficile in hospitals.

Pedro Cahn, MD, explains who the target population is for raltegravir HD.

Richard Haupt, MD, MPH, discusses the process for developing a vaccine.

Robert Bransfield, MD, DLFAPA, explains how psychoneuroimmunology can work to bridge the gap between psychiatrists and infectious disease physicians to improve patient care.

Edmond Hooker, MD, DrPH, explains how regulatory agencies are “turning a blind eye” to an important issue experienced in hospitals everywhere.